Skip Nav Destination
Issues
1 May 2024
-
Cover Image
Cover Image
GNAS mutations contribute to pancreatic intraductal papillary mucinous neoplasm (IPMN) formation, but underlying mechanisms—and cell type specificity therein—have yet to be delineated. In their study on page 440, Desai and colleagues interrogated cell type-specific GNASR201C signaling in human stem cell-derived pancreatic ductal and acinar organoids containing doxycycline-inducible GNASR201C. The authors found that GNASR201C induced IPMN-like growth and cell proliferation more readily in ductal than acinar organoids, and that those phenotypes were uniquely protein kinase A (PKA)-independent in ductal organoids. The cover features a confocal image of a GNASR201C-expressing pancreatic ductal organoid section in the presence of a pharmacologic PKA inhibitor, where proliferating cells are labeled with Edu (white) and DAPI-stained nuclei fluoresce purple. This study is also Highlighted on page 421. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1541-7786
EISSN 1557-3125
Journal Archive
Molecular Cancer Research (2002-Present; volumes 1-current)
(ISSN 0008-5472) Published monthly since November, 2002.Cell Growth & Differentiation (1990-2002; volumes 1-13)
(ISSN 1044-9523) Published monthly 1990- September, 2002.Table of Contents
Highlights
Cancer Genes and Networks
Cancer Research Resources
Metabolism
New Horizons in Cancer Biology
Tumor Microenvironment and Immunobiology
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.